Apple Watch is expected to support blood glucose monitoring
With the rapid development of technology, the functions of smart wearable devices in health monitoring are becoming more complete. Major manufacturers continue to introduce new technologies into their smart wearable devices to further provide wearers with more comprehensive health monitoring.
A few days ago, according to The Telegraph and Forbes, the British start-up company Rockley Photonics is preparing to go public on the New York Stock Exchange. This company has deep technical accumulation and strength in the technology of blood glucose measurement. According to public information, Apple is one of Rockley Photonics’ very important customers. Apple and another major customer accounted for 99.6% of the company’s total revenue in 2019, and 100% in 2020. According to sources, Rockley Photonic is negotiating with Apple to sign supply and development-related matters.
The company’s CEO said that the blood glucose detection technology it developed will be applied to consumer products in 2022. The use of this technology will greatly improve the convenience of blood glucose measurement, and the sensor can be used to monitor blood glucose levels.
In this regard, some outsiders pointed out that the technology will be applied to the next-generation Apple Watch, but the company’s CEO refused to disclose whether the product is related to Apple.
It is worth mentioning that Apple submitted a new patent application to the US Patent and Trademark Office. The patent shows that it is planning to launch a technology that allows Apple Watch to emit radio frequency, and then calculate the degree of radiofrequency absorption and finally obtain blood glucose readings.